Rivaroxaban for acute deep venous thrombosis When we have a standard therapy for a disease, in this case vitamin K antagonists (VKA) for deep venous thrombosis (DVT), and a new therapy comes out, what do we want to know about the new drug? Is it at least as effective as the old therapy? Because if […]
Scott Weingart joins ERcast to give his take on 3 factor PCC and FEIBA.
Reversing Anticoagulation – A How to Guide (adapted from podcast interview with Tom Deloughery)